UBS Group’s Quipt Home Medical QIPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-202,552
| Closed | -$715K | – | 11035 |
|
|
2025
Q4 | $715K | Buy |
202,552
+201,486
| +18,901% | +$533K | ﹤0.01% | 5848 |
|
|
2025
Q3 | $2.78K | Sell |
1,066
-22,024
| -95% | -$50.9K | ﹤0.01% | 9121 |
|
|
2025
Q2 | $41.3K | Buy |
23,090
+7,615
| +49% | +$15K | ﹤0.01% | 7927 |
|
|
2025
Q1 | $36.1K | Sell |
15,475
-7,004
| -31% | -$19.2K | ﹤0.01% | 7827 |
|
|
2024
Q4 | $68.6K | Buy |
22,479
+2,845
| +14% | +$7.66K | ﹤0.01% | 7101 |
|
|
2024
Q3 | $57.3K | Buy |
19,634
+6,904
| +54% | +$21.3K | ﹤0.01% | 6728 |
|
|
2024
Q2 | $41K | Sell |
12,730
-29,106
| -70% | -$104K | ﹤0.01% | 6843 |
|
|
2024
Q1 | $183K | Buy |
41,836
+514
| +1% | +$2.32K | ﹤0.01% | 5917 |
|
|
2023
Q4 | $210K | Buy |
41,322
+20,990
| +103% | +$101K | ﹤0.01% | 5755 |
|
|
2023
Q3 | $103K | Sell |
20,332
-4,489
| -18% | -$24.1K | ﹤0.01% | 5813 |
|
|
2023
Q2 | $133K | Buy |
24,821
+24,591
| +10,692% | +$145K | ﹤0.01% | 5792 |
|
|
2023
Q1 | $1.61K | Buy |
+230
| New | +$1.42K | ﹤0.01% | 8695 |
|
|
2022
Q3 | – | Sell |
-2,831
| Closed | -$13K | – | 10809 |
|
|
2022
Q2 | $13K | Sell |
2,831
-169
| -6% | -$779 | ﹤0.01% | 7541 |
|
|
2022
Q1 | $13K | Hold |
3,000
| – | – | ﹤0.01% | 8070 |
|
|
2021
Q4 | $17K | Hold |
3,000
| – | – | ﹤0.01% | 8075 |
|
|
2021
Q3 | $19K | Sell |
3,000
-750
| -20% | -$4.5K | ﹤0.01% | 7218 |
|
|
2021
Q2 | $24K | Buy |
+3,750
| New | +$23K | ﹤0.01% | 7146 |
|
UBS Group's QIPT Position: Q1 2026 in Review
UBS Group sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 202,552 shares — an estimated $715K sold.
UBS Group first reported a position in QIPT in Q2 2021 and held it in 17 quarters. The position peaked at $715K in Q4 2025. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.
- UBS Group reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 202,552 Quipt Home Medical shares in Q1 2026, an estimated $715K.
- UBS Group first reported a position in Quipt Home Medical in Q2 2021 and held it in 17 quarters.
- UBS Group's Quipt Home Medical position peaked at $715K in Q4 2025.
- 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.